12.09.2013 Views

BIOPIRACY Imitations Not Innovations - Biopirateria

BIOPIRACY Imitations Not Innovations - Biopirateria

BIOPIRACY Imitations Not Innovations - Biopirateria

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Biopiracy: <strong>Imitations</strong> <strong>Not</strong> <strong>Innovations</strong> 17<br />

International Treaty on Plant Genetic Resources for Food and Agriculture. The<br />

objectives of the treaty are the conservation and sustainable use of plant genetic<br />

resources for food and agriculture, and the fair and equitable sharing of the<br />

benefits arising out of their use, in harmony with the CBD, for sustainable<br />

agriculture and food security. Though this treaty deals specially with the<br />

indigenous knowledge related to food and agriculture, it reflects the importance<br />

and recognition accorded to IK per se.<br />

Despite the fact that efforts are being made in various international fora for<br />

the protection and recognition of IK, corresponding efforts are not being reflected<br />

in intellectual property regimes of the user nations. In the near absence of<br />

national legislation on bio-prospecting, the commercialization of biotech products<br />

and processes, based on genetic resources obtained from developing countries,<br />

continues to be based on free market principles of demand and supply.<br />

By definition, patents cannot be granted for substances that exist in nature<br />

as these do not fulfil the criterion of novelty or inventive step. However, the<br />

procedures followed in determining the novelty of patentable inventions differ<br />

even among industrialized countries. Developing countries rightly believe that<br />

patent systems that do not provide searching for the written and oral prior art<br />

for worldwide novelty (such as is the case in US) and that do not insist on<br />

disclosure of the origin and proof of prior informed consent, as few countries do<br />

today, for the use of the biological materials or IK on which the invention is<br />

based, help in perpetuating the inequitable system. One prime cause for this<br />

situation is that the international agreements/treaties relevant to the protection<br />

and recognition of IK lack mechanisms required for its enforcement. International<br />

conventions and treaties dealing with IK are characterized by the fact that they<br />

are not binding. Every clause that deals with benefit-sharing is contested and<br />

refused. ILO Convention No. 169, which says a lot about legal standards for<br />

indigenous rights, fails to protect the IPR of indigenous people. Whereas the<br />

UN Declaration on the Rights of Indigenous People recognizes the rights and<br />

aspirations of the Indigenous People, it is a non-binding document, which<br />

cannot be legally enforced. In the International Treaty on Plant Genetic Resources,<br />

developed nations have successfully blocked the international recognition of<br />

Farmers’ Rights. They also contest any notion of paying for the use of traditional<br />

germplasm in a benefit-sharing arrangement. The CBD, which has attempted<br />

to push through the interests of IK, has been thwarted by the American refusal<br />

to ratify it and accept its conditions. International agreements of this kind are<br />

not binding on the nations signatory to them nor are there any provisions that<br />

would compel the nations to implement provisions of these agreements. The

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!